医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
24期
136-137
,共2页
米索前列醇%缩宫素%产后出血%疗效观察
米索前列醇%縮宮素%產後齣血%療效觀察
미색전렬순%축궁소%산후출혈%료효관찰
Misoprostol%Oxytocin%Postpartum Hemorrhage%Clinical Effect Observation
目的:观察米索前列醇联合缩宫素防治产后出血的疗效。方法选取我院足月顺产产妇118例,分为观察组与缩宫素组,各59例。观察组给米索前列醇予600μg口服,并肌注缩宫素20U;缩宫素组仅给予缩宫素肌注。比较两组产妇第三产程时间及产后2h、24h内出血量及出血率。结果观察组第三产程时间为(9.2±2.9)min,低于缩宫素组的(16.7±5.6)min;此外,观察组2h、24h出血量分别为(86.7±6.4)ml、(126.2±9.4)ml远低于缩宫素组的(240.8±22.1)ml、(369.5±38.6)ml,观察组出血率1.69%,亦低于缩宫素组的20.34%。所有数据均符合统计学差异(P<0.05)。结论米索前列醇可有效弥补缩宫素在防治产后出血的不足,两药合用,效果显著,值得推广。
目的:觀察米索前列醇聯閤縮宮素防治產後齣血的療效。方法選取我院足月順產產婦118例,分為觀察組與縮宮素組,各59例。觀察組給米索前列醇予600μg口服,併肌註縮宮素20U;縮宮素組僅給予縮宮素肌註。比較兩組產婦第三產程時間及產後2h、24h內齣血量及齣血率。結果觀察組第三產程時間為(9.2±2.9)min,低于縮宮素組的(16.7±5.6)min;此外,觀察組2h、24h齣血量分彆為(86.7±6.4)ml、(126.2±9.4)ml遠低于縮宮素組的(240.8±22.1)ml、(369.5±38.6)ml,觀察組齣血率1.69%,亦低于縮宮素組的20.34%。所有數據均符閤統計學差異(P<0.05)。結論米索前列醇可有效瀰補縮宮素在防治產後齣血的不足,兩藥閤用,效果顯著,值得推廣。
목적:관찰미색전렬순연합축궁소방치산후출혈적료효。방법선취아원족월순산산부118례,분위관찰조여축궁소조,각59례。관찰조급미색전렬순여600μg구복,병기주축궁소20U;축궁소조부급여축궁소기주。비교량조산부제삼산정시간급산후2h、24h내출혈량급출혈솔。결과관찰조제삼산정시간위(9.2±2.9)min,저우축궁소조적(16.7±5.6)min;차외,관찰조2h、24h출혈량분별위(86.7±6.4)ml、(126.2±9.4)ml원저우축궁소조적(240.8±22.1)ml、(369.5±38.6)ml,관찰조출혈솔1.69%,역저우축궁소조적20.34%。소유수거균부합통계학차이(P<0.05)。결론미색전렬순가유효미보축궁소재방치산후출혈적불족,량약합용,효과현저,치득추엄。
Objective To observe the clinical ef ect of misoprostol combined oxytocin for treatment of postpartum hemorrhage. Method:118 puerperas delivered in natural way with ful term were divided into observation group and control group both with 59 cases. Observation group was given misoprostol 600μg oral y and oxytocin 20U intramuscularly;control group was given only oxytocin. The third labor time and bleeding amount and bleeding rate 2h and 24h after delivery of the 2 groups were compared. Result:The third labor time of observation group was (9.2±2.9) min shorter than control group (16.7±5.6) min;bleeding amount 2h and 24h after delivery of observation group was (86.7±6.4) and (126.2±9.4) obviously less than control group (240.8±22.1) ml and (369.5±38.6).Bleeding rate of observation group was 1.69%lower than control group 20.34%(P<0.05). Conclusion:Misoprostol can ef ectively compensate the shortage of oxytocin in preventing and treating postpartum hemorrhage.The combination of the 2 drugs can produce a significant ef ect,so it's worth of being popularized.